Bio-rad Laboratories, Inc. (BIO) Financial Statements
Industry: Laboratory Analytical Instruments
In fiscal 2025, Bio-rad Laboratories reported revenue of $2.58B, up 0.7% from $2.57B the year before. Net income was $759.9M (a 29.4% net margin), or $27.85 per diluted share. Gross margin was 51.9% and operating margin was 1.8%. Operating activities generated $532.2M of cash, leaving $374.6M of free cash flow. At fiscal year end, Bio-rad Laboratories held $10.58B in total assets against $3.12B in total liabilities, including $529.8M of cash and equivalents.
Open the full interactive Bio-rad Laboratories financials → Quarterly statements, key ratios, valuation history and price charts.
Bio-rad Laboratories Key Stats
| Share Price | $363.73 |
|---|---|
| Market Cap | $9.75B |
| P/E Ratio | 13.1 |
| Revenue YoY Growth | +0.7% |
| 52-Week Range | $241.71 – $390.34 |
| Shares Outstanding | 26.7 million (basic, 2026 Q2) |
Bio-rad Laboratories Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.55B | $2.92B | $2.80B | $2.67B | $2.57B | $2.58B |
| Cost of Goods Sold | $1.11B | $1.28B | $1.23B | $1.24B | $1.19B | $1.24B |
| Gross Profit | $1.44B | $1.64B | $1.57B | $1.43B | $1.38B | $1.34B |
| Operating Income | $411.0M | $489.4M | $482.6M | $337.8M | $269.0M | $47.2M |
| Pre-Tax Income | $4.91B | $5.44B | -$4.70B | -$850.1M | -$2.34B | $995.5M |
| Income Tax | $1.10B | $1.19B | -$1.08B | -$212.8M | -$498.3M | $235.6M |
| Net Income | $3.81B | $4.25B | -$3.63B | -$637.3M | -$1.84B | $759.9M |
| Diluted EPS | $126.20 | $140.56 | -$121.79 | -$21.82 | -$25.57 | $27.85 |
Bio-rad Laboratories Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $653.0M | $693.2M | $592.1M | $651.0M |
| Net Income | -$341.9M | $720.0M | -$527.1M | $371.4M |
| Diluted EPS | -$12.70 | $26.39 | -$19.55 | $13.85 |
Bio-rad Laboratories Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $662.2M | $470.8M | $434.2M | $403.8M | $488.1M | $529.8M |
| Current Assets | $2.14B | $1.99B | $3.16B | $3.05B | $3.03B | $2.91B |
| Total Assets | $12.97B | $17.78B | $13.50B | $12.30B | $9.36B | $10.58B |
| Current Liabilities | $631.5M | $680.9M | $568.7M | $522.8M | $467.8M | $517.0M |
| Total Long-Term Debt | $12.3M | $10.5M | $1.20B | $1.20B | $1.20B | $1.20B |
| Total Liabilities | $3.09B | $4.11B | $3.89B | $3.56B | $2.79B | $3.12B |
| Shareholders' Equity | $9.88B | $13.67B | $9.62B | $8.74B | $6.57B | $7.45B |
Bio-rad Laboratories Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $575.3M | $656.5M | $194.4M | $374.9M | $455.2M | $532.2M |
| Cash From Investing | -$60.2M | -$784.4M | -$1.21B | $20.2M | -$160.2M | -$189.7M |
| Cash From Financing | -$523.0M | -$55.4M | $973.6M | -$425.6M | -$218.8M | -$283.2M |
| Free Cash Flow | $476.4M | $535.7M | $81.6M | $218.2M | $289.6M | $374.6M |
Figures from Bio-rad Laboratories' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Bio-rad Laboratories financials page for every line item.
Bio-rad Laboratories Company Profile
| Ticker | BIO |
|---|---|
| Exchange | NYSE |
| Industry | Laboratory Analytical Instruments |
| Headquarters | Hercules, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000012208 |
Frequently Asked Questions
What was Bio-rad Laboratories' revenue in fiscal 2025?
Bio-rad Laboratories (BIO) reported revenue of $2.58B for fiscal 2025.
What is Bio-rad Laboratories' annual revenue history?
Bio-rad Laboratories' annual revenue by fiscal year: 2020: $2.55B; 2021: $2.92B; 2022: $2.80B; 2023: $2.67B; 2024: $2.57B; 2025: $2.58B.
What was Bio-rad Laboratories' net income in fiscal 2025?
Bio-rad Laboratories reported net income of $759.9M for fiscal 2025.
What was Bio-rad Laboratories' earnings per share (EPS) in fiscal 2025?
Bio-rad Laboratories' diluted EPS was $27.85 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Bio-rad Laboratories generate in fiscal 2025?
Bio-rad Laboratories generated $374.6M of free cash flow in fiscal 2025.
What was Bio-rad Laboratories' revenue last quarter?
In its most recent reported quarter (2026 Q2), Bio-rad Laboratories reported revenue of $651.0M.
How much debt does Bio-rad Laboratories have?
Bio-rad Laboratories reported $1.20B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Bio-rad Laboratories are outstanding?
Bio-rad Laboratories reported a weighted average of 26.7 million basic shares outstanding in 2026 Q2.
What is Bio-rad Laboratories' market cap?
Based on its latest closing price, Bio-rad Laboratories (BIO) has a market capitalization of about $9.75B.
When does Bio-rad Laboratories' fiscal year end?
Bio-rad Laboratories' fiscal year end, as registered with the SEC, is December 31.
Where is Bio-rad Laboratories headquartered?
Bio-rad Laboratories lists its business address in Hercules, California in its SEC filings.